Vice President, Commercial Operations at Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Experience establishing and leading commercial operations in a pharmaceutical or biotech company
Proven track record in building commercial infrastructure from the ground up for product launches
Strategic partnership experience across functions including Sales, Marketing, Market Access, Patient Services, Medical Affairs, Finance, IT, and Compliance
Expertise in sales operations, forecasting, analytics, incentive compensation, market research, data management, CRM systems, field effectiveness, and commercial training

Responsibilities

Serve as a key member of the Commercial Leadership Team, developing and executing commercial strategy and operational plans
Oversee the design and optimization of commercial operations, including market research, forecasting, data analytics, sales reporting, and performance tracking
Develop a best-in-class commercial infrastructure that aligns with business objectives and supports pre-launch and post-launch activities
Lead Quarterly Business Reviews (QBR) and Board of Directors (BoD) process preparation, including performance reporting and insights
Partner cross-functionally with Marketing, Sales, Finance, Compliance, Market Access, and Medical Affairs to drive aligned strategic execution
Design and implement field force structure, including sizing, territory alignment, and resource allocation
Oversee field effectiveness, including CRM system implementation, sales enablement tools, and customer engagement reporting
Develop and manage incentive compensation plans to motivate and retain top sales talent while ensuring compliance
Establish field insights and reporting frameworks, providing timely and data-driven recommendations to sales leadership
Support field training and development programs in collaboration with Sales Training teams
Lead the development and governance of commercial data strategy, ensuring seamless integration and utilization of sales, claims, specialty pharmacy, and CRM data
Develop competitive intelligence, customer targeting methodologies, and KPIs to assess commercial performance
Design dashboards, analytics tools, and reporting mechanisms that provide actionable insights for leadership decision-making
Partner with IT and external vendors to build and maintain a commercial data environment (CDE) that supports sales forecasting, revenue tracking, and strategic planning
Manage commercial operations budgets, ensuring efficient allocation of human and financial resources
Drive process improvements, system enhancements, and operational efficiencies to optimize commercial execution
Oversee congress and event operations

Skills

Sales Operations

Forecasting

Analytics

Incentive Compensation

Market Research

Data Management

CRM Systems

Commercial Training

Commercial Strategy

Amylyx Pharmaceuticals

Develops treatments for neurodegenerative diseases

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials to assess its effectiveness. The CENTAUR ALS trial showed promising results for ALS patients, using a randomized, double-blind, placebo-controlled design to ensure reliable outcomes. They are also conducting the PEGASUS trial to evaluate AMX0035's safety and effectiveness in Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes and enhance the quality of life for individuals suffering from neurodegenerative conditions.

Cambridge, MassachusettsHeadquarters

2013Year Founded

$166.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Relyvrio's Phase III failure raises concerns about ALS treatment efficacy.

Low stock offering price suggests potential financial instability.

New CCO may disrupt commercialization strategies if not aligned with goals.

Differentiation

Amylyx focuses on neurodegenerative diseases like ALS and Alzheimer's.

AMX0035 is a promising drug for ALS and Alzheimer's treatment.

Amylyx engages in community awareness campaigns for neurodegenerative diseases.

Upsides

Positive Phase II results for AMX0035 in ALS boost its potential.

Partnership with Gubra accelerates drug development for neurodegenerative diseases.

Regulatory support for rare diseases aids Amylyx's Wolfram syndrome efforts.

Land your dream remote job 3x faster with AI

Try Jobo Free